Platelet dysfunction in a large-animal model of endotoxic shock; effects of inhaled nitric oxide and low-dose steroid

Nitric Oxide. 2021 Mar 1:108:20-27. doi: 10.1016/j.niox.2020.12.008. Epub 2021 Jan 2.

Abstract

Objective: The role of inhaled nitric oxide in the treatment of shock remains controversial and further translational research is needed. Long-term observation studies using a model of endotoxin-induced shock to assess the effect of inhaled nitric oxide on platelet aggregation have not yet been reported.

Approach and results: The tests were carried out in an animal model of shock in two 10-h periods. During the first 10 h, endotoxin was infused and the inhibition of platelet aggregation was evaluated; following the termination of endotoxin infusion, the restoration of platelet aggregation was assessed for 10 h. A total of 30 pigs were used (NO group, N = 14; control, N = 16). In the NO group, nitric oxide inhalation (30 ppm) was started 3 h after endotoxin infusion and continued until the end of the study. Treatment with NO selectively decreased pulmonary artery pressure at 4 (p = 0.002) and 8 h (p = 0.05) of the experiment as compared to the control. Endotoxin significantly reduced platelet aggregation, as indicated by the decreased activity of platelet receptors: ASPI, ADP, collagen, and TRAP during the experiment (p < 0.001). Endotoxin had no significant effect on changes in the response of the receptor after ristocetin stimulation. After stopping endotoxin infusion, a significant restoration of receptor activity was observed for collagen and TRAP, while ASPI and ADP remained partially depressed. Inhaled nitric oxide did not cause additional inhibition of platelet aggregation, either during or after endotoxin challenge.

Conclusions: A profound reduction in platelet aggregation was observed during endotoxic shock. After stopping endotoxin infusion a restoration of platelet receptor activity was seen. The inhibition of platelet aggregation induced by endotoxin infusion was not intensified by nitric oxide, indicating there was no harmful effect of inhaled nitric oxide on platelet aggregation.

Keywords: Aggregometry; Endotoxemia; Inhaled nitric oxide; Platelets; Pulmonary hypertension; Shock.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Animals
  • Blood Platelets / metabolism*
  • Endotoxins
  • Hydrocortisone / therapeutic use
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / therapeutic use*
  • Platelet Aggregation / drug effects*
  • Pulmonary Wedge Pressure / drug effects
  • Shock, Septic / chemically induced
  • Shock, Septic / drug therapy*
  • Shock, Septic / metabolism
  • Swine
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Endotoxins
  • Vasodilator Agents
  • Nitric Oxide
  • Hydrocortisone